Innovator IBD® 50 ETF | FFTYFür den Zugriff auf unsere Ratings hier anmelden |
Wie hat sich dieser Fonds entwickelt? | 31.05.2025 |
Wachstum von 1000 (EUR) | Charts Erweitert |
![]() | Fonds | 20,4 | -47,9 | 8,6 | 26,5 | -4,5 |
![]() | +/-Kat | -1,2 | -24,8 | -8,7 | 2,2 | 4,7 |
![]() | +/-Idx | -18,1 | -35,1 | -13,4 | -6,9 | 3,3 |
Kategorie: Mid-Cap Growth | ||||||
Kategorie Benchmark: S&P 500 TR USD |
Übersicht | ||
Schlusskurs 05.06.2025 | USD 30,43 | |
Änderung z. Vortag (in EUR) | -1,12% | |
Ausgabeaufschlag | - | |
Morningstar Kategorie™ | Mid-Cap Growth | |
WKN | A2JSPB | |
Volumen | 30705 | |
Börse | NEW YORK STOCK EXCHANGE, INC. | |
ISIN | US45782C1027 | |
Fondsvolumen (Mio) - | - | |
Anteilsklassenvol (Mio) 04.06.2025 | USD 76,75 | |
Laufende Kosten - | -% |
Anlageziel: Innovator IBD® 50 ETF | FFTY |
The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks. |
Returns | |||||||||||||
|
Management | ||
Fondsmanager Startdatum | ||
Dustin Lewellyn 20.11.2017 | ||
Ernesto Tong 20.11.2017 | ||
Click here to see others | ||
Anteilserstausgabe 08.04.2015 |
Werbung |
Kategorie Benchmark | |
Fondsbenchmark | Morningstar Benchmark |
IBD 50 Index USD | S&P 500 TR USD |
Target Market | ||||||||||||||||||||
|
Was steckt in diesem Fonds? Innovator IBD® 50 ETF | FFTY | 03.06.2025 |
|
|
Top 5 Positionen | Sektor | % |
![]() | ![]() | 4,43 |
![]() | ![]() | 3,68 |
![]() | ![]() | 3,57 |
![]() | ![]() | 3,51 |
![]() | ![]() | 3,51 |
![]() | ||
![]() ![]() ![]() | ||
Innovator IBD® 50 ETF | FFTY |